Neurobiology of Psychiatric Disorders
Core concept: Psychiatric symptoms arise from interactions among neural networks, developmental factors, and psychological and social experience; they cannot be reduced to one neurotransmitter abnormality.
Key clinical distinction: Shared symptoms can reflect different circuits or medical conditions. Pattern, time course, functional change, and context determine the differential.
Clinical priority: Assess acute changes, medical causes, functional impairment, and immediate safety before deciding whether a psychiatric syndrome best explains the presentation.
Pathophysiology
Neural circuits and dimensions
Psychiatric illness arises from interacting neurodevelopmental, genetic, environmental, psychological, and social processes. Relevant networks include prefrontal executive regulation, limbic salience and threat processing, corticostriatal reward/motivation, and distributed systems supporting attention, mood, and perception (Marcus, 2019).
Neurotransmission and limits of inference
Dopaminergic, serotonergic, noradrenergic, GABAergic, and glutamatergic signaling are implicated in models of psychiatric illness (Kelly & Borovicka, 2026; Kneebusch & Tiefenthaler, 2026). Their contributions are circuit-specific; simple “chemical imbalance” models do not adequately explain an individual diagnosis. Medication response alone does not establish a single causal neurotransmitter deficiency.
Network-to-symptom examples and limits of causation
Prefrontal networks contribute to attention, executive control, response inhibition, and planning; limbic and salience networks influence emotional learning and threat detection; striatal and dopaminergic circuits participate in reward prediction, motivation, and motor behavior. Sleep and circadian systems interact with arousal, emotion regulation, and cognition. These networks overlap, making one-to-one symptom-to-neurotransmitter claims unreliable. Mood, anxiety, psychosis, trauma responses, and cognitive disorders reflect combinations of vulnerability, development, physiological state, stressors, and social context. A medication’s ability to change a transmitter does not prove that a disorder was caused by a simple deficiency of that transmitter (Jackson, 2026; Kelly & Borovicka, 2026).
Neurodevelopment, circadian regulation, and stress physiology
Neurodevelopmental processes influence synaptic pruning, inhibition, cortical connectivity, and susceptibility to later mental illness, but circuit-level findings are group associations rather than individual diagnostic tests. Circadian timing and sleep-wake disruption can interact with mood activation, cognition, anxiety, and perceptual experiences; disturbed sleep can be both a driver and a consequence of illness. The hypothalamic-pituitary-adrenal axis links threat appraisal to cortisol signaling and autonomic change, yet cortisol levels do not diagnose an individual mood or anxiety disorder. Clinically useful formulations integrate inherited vulnerability, developmental experience, medications, inflammation or systemic disease, psychosocial conditions, and longitudinal symptom patterns (Jackson, 2026; Kneebusch & Tiefenthaler, 2026).
Distinguish neurotransmitter targets of treatment from established causes of illness. Modulating dopamine D2 signaling can reduce positive psychotic symptoms, but that response does not prove dopamine excess is the sole cause of schizophrenia (Kelly & Borovicka, 2026). Antidepressants modify monoaminergic and other signaling pathways; their effectiveness does not establish an individual serotonin or norepinephrine deficiency (Jackson, 2026). Clinical diagnosis still depends on syndrome, longitudinal course, functional impact, and medical or substance-related exclusions.
Diagnostic Evaluation
Operational assessment: separate state, syndrome, and safety
First determine whether a mental-status change is new, fluctuating, and accompanied by impaired attention or arousal; if so, investigate delirium and medical causes urgently (Marcus, 2019). Next distinguish persistent psychiatric syndromes by onset, duration, episodicity, symptom clusters, functional impact, and exposure to medication or substances. Cognitive testing, neurologic examination, sleep assessment, suicidality and violence risk review, and collateral history should be selected by presentation. A defensible neurobiologic explanation identifies what is known, what is hypothesized, and how the uncertainty affects—not prevents—clinical evaluation.
Clinical Reasoning Priorities
Applied case: medical cause versus psychiatric syndrome
A hospitalized older adult suddenly becomes distractible and hallucinates after an infection and sedating medication exposure. Inattention, fluctuating arousal, and abrupt onset favor delirium, irrespective of whether the experiences sound psychotic. A younger adult with months of persistent hallucinations and declining social function but stable alertness needs a different longitudinal evaluation. Assess whether mental status is acutely physiologically impaired before assigning a primary psychiatric syndrome; theoretical transmitter mechanisms do not substitute for safety assessment (Marcus, 2019; Kelly & Borovicka, 2026).
Related YourDNP Guides
- Back to Pathophysiology
- Pharmacogenomics
- Rational Drug Selection
- Depressive and Bipolar Mood Disorders
- Schizophrenia Spectrum Disorders
Content last reviewed:
References
Jackson, C. W. (2026). Major depressive disorder. In M. A. Chisholm-Burns, P. M. Malone, J. M. Kolesar, K. C. Lee, P. B. Bookstaver, & K. R. Matthias (Eds.), Pharmacotherapy principles & practice (7th ed.). McGraw Hill.
Kelly, D. L., & Borovicka, M. (2026). Schizophrenia. In M. A. Chisholm-Burns, P. M. Malone, J. M. Kolesar, K. C. Lee, P. B. Bookstaver, & K. R. Matthias (Eds.), Pharmacotherapy principles & practice (7th ed.). McGraw Hill.
Kneebusch, J., & Tiefenthaler, C. (2026). Anxiety-related disorders. In M. A. Chisholm-Burns, P. M. Malone, J. M. Kolesar, K. C. Lee, P. B. Bookstaver, & K. R. Matthias (Eds.), Pharmacotherapy principles & practice (7th ed.). McGraw Hill.
Marcus, E. R. (2019). Psychiatric disorders. In J. C. M. Brust (Ed.), CURRENT diagnosis & treatment: Neurology (3rd ed.). McGraw-Hill Education.